Literature DB >> 22974367

Functional PLGA NPs for oral drug delivery: recent strategies and developments.

L Martin-Banderas1, M Durán-Lobato, I Muñoz-Rubio, J Alvarez-Fuentes, M Fernández-Arevalo, M A Holgado.   

Abstract

This article presents the potential of PLGA nanoparticles for the oral administration of drugs. Different strategies are used to improve oral absorption of these nanoparticles. These strategies are based on modification of nanoparticle surface properties. They can be achieved either by coating the nanoparticle surface with stabilizing hydrophilic bioadhesive polymers or surfactants, or by incorporating biodegradable copolymers containing a hydrophilic moiety. Some substances such as chitosan, vitamin E, methacrylates, lectins, lecithins, bile salts and RGD molecules are employed for this purpose. Of especial interest are nanoparticles production methods and, in order to improve oral bioavailability, the mechanism of each additive.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22974367

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  11 in total

1.  In vitro controlled release of antigen in dendritic cells using pH-sensitive liposome-polymeric hybrid nanoparticles.

Authors:  Yun Hu; Zongmin Zhao; Marion Ehrich; Kristel Fuhrman; Chenming Zhang
Journal:  Polymer (Guildf)       Date:  2015-12-02       Impact factor: 4.430

2.  Design of Insulin-Loaded Nanoparticles Enabled by Multistep Control of Nanoprecipitation and Zinc Chelation.

Authors:  Sunandini Chopra; Nicolas Bertrand; Jong-Min Lim; Amy Wang; Omid C Farokhzad; Rohit Karnik
Journal:  ACS Appl Mater Interfaces       Date:  2017-03-21       Impact factor: 9.229

Review 3.  Nanotechnology in retinal drug delivery.

Authors:  Sibo Jiang; Yesenia L Franco; Yan Zhou; Jianjun Chen
Journal:  Int J Ophthalmol       Date:  2018-06-18       Impact factor: 1.779

4.  Quantification of particle-conjugated or particle-encapsulated peptides on interfering reagent backgrounds.

Authors:  Woon Teck Yap; W Kelsey Song; Niharika Chauhan; P Nina Scalise; Radhika Agarwal; Stephen D Miller; Lonnie D Shea
Journal:  Biotechniques       Date:  2014-07-01       Impact factor: 1.993

5.  Glucose-Based Mesoporous Carbon Nanospheres as Functional Carriers for Oral Delivery of Amphiphobic Raloxifene: Insights into the Bioavailability Enhancement and Lymphatic Transport.

Authors:  Yanghuan Ye; Tianpeng Zhang; Wan Li; Hua Sun; Danyi Lu; Baojian Wu; Xingwang Zhang
Journal:  Pharm Res       Date:  2015-11-09       Impact factor: 4.200

6.  Enhancement of oral bioavailability of cyclosporine A: comparison of various nanoscale drug-delivery systems.

Authors:  Kai Wang; Jianping Qi; Tengfei Weng; Zhiqiang Tian; Yi Lu; Kaili Hu; Zongning Yin; Wei Wu
Journal:  Int J Nanomedicine       Date:  2014-10-28

7.  Gold nanoparticle-based miR155 antagonist macrophage delivery restores the cardiac function in ovariectomized diabetic mouse model.

Authors:  Chengming Jia; Hui Chen; Mengying Wei; Xiangjie Chen; Yajun Zhang; Liang Cao; Ping Yuan; Fangyuan Wang; Guodong Yang; Jing Ma
Journal:  Int J Nanomedicine       Date:  2017-07-11

8.  Accelerated wound healing by injectable star poly(ethylene glycol)-b-poly(propylene sulfide) scaffolds loaded with poorly water-soluble drugs.

Authors:  Suwei Zhu; Shuoran Li; Helena Escuin-Ordinas; Robert Dimatteo; Weixian Xi; Antoni Ribas; Tatiana Segura
Journal:  J Control Release       Date:  2018-05-09       Impact factor: 11.467

9.  Periadventitial application of rapamycin-loaded nanoparticles produces sustained inhibition of vascular restenosis.

Authors:  Xudong Shi; Guojun Chen; Lian-Wang Guo; Yi Si; Men Zhu; Srikanth Pilla; Bo Liu; Shaoqin Gong; K Craig Kent
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

10.  Elaboration of Charged Poly(Lactic-co-Glycolic Acid) Microparticles for Effective Release of Tranexamic Acid.

Authors:  Ming-Hsi Huang; Shun-Ying Huang; Yi-Xuan Chen; Cheng-You Chen; Yung-Sheng Lin
Journal:  Polymers (Basel)       Date:  2020-04-04       Impact factor: 4.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.